Yifan Xinfu Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of September 2024: 0.53%

Yifan Xinfu Pharmaceutical Co Ltd asset resilience ratio. Yifan Xinfu Pharmaceutical Co Ltd (002019) has an Asset Resilience Ratio of 0.53% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 002019 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥65.00 Million
≈ $9.51 Million USD Cash + Short-term Investments

Total Assets

CN¥12.37 Billion
≈ $1.81 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Yifan Xinfu Pharmaceutical Co Ltd (2015–2023)

Asset resilience ratio of Yifan Xinfu Pharmaceutical Co Ltd from 2015 to 2023. This chart shows how Yifan Xinfu Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Yifan Xinfu Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Yifan Xinfu Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Yifan Xinfu Pharmaceutical Co Ltd asset portfolio.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥65.00 Million 0.53%
Total Liquid Assets CN¥65.00 Million 0.53%

Asset Resilience Insights

  • Limited Liquidity: Yifan Xinfu Pharmaceutical Co Ltd maintains only 0.53% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Yifan Xinfu Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Yifan Xinfu Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Merck & Company Inc
NYSE:MRK
Drug Manufacturers - General 0.22%
AstraZeneca PLC
NASDAQ:AZN
Drug Manufacturers - General 0.10%
Pfizer Inc
SA:PFIZ34
Drug Manufacturers - General 5.33%
Novartis AG
MX:NVSN
Drug Manufacturers - General 0.08%
Pfizer Inc
NYSE:PFE
Drug Manufacturers - General 5.33%
Novo Nordisk A/S
CO:NOVO-B
Drug Manufacturers - General 0.09%
Zhejiang Int'L Group Co Ltd
SHE:000411
Drug Manufacturers - General 0.00%
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR
Drug Manufacturers - General 0.07%

Yifan Xinfu Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2015–2023)

Yifan Xinfu Pharmaceutical Co Ltd asset resilience ratio by year from 2015 to 2023. The table below shows the annual Asset Resilience Ratio data for Yifan Xinfu Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 0.65% CN¥75.01 Million
≈ $10.98 Million
CN¥11.50 Billion
≈ $1.68 Billion
-0.11pp
2022-12-31 0.76% CN¥95.50 Million
≈ $13.97 Million
CN¥12.54 Billion
≈ $1.84 Billion
-2.86pp
2021-12-31 3.62% CN¥440.39 Million
≈ $64.44 Million
CN¥12.17 Billion
≈ $1.78 Billion
+3.22pp
2020-12-31 0.40% CN¥46.73 Million
≈ $6.84 Million
CN¥11.71 Billion
≈ $1.71 Billion
+0.05pp
2019-12-31 0.35% CN¥39.00 Million
≈ $5.71 Million
CN¥11.07 Billion
≈ $1.62 Billion
-1.03pp
2018-12-31 1.39% CN¥135.58 Million
≈ $19.84 Million
CN¥9.77 Billion
≈ $1.43 Billion
-6.37pp
2017-12-31 7.76% CN¥680.00 Million
≈ $99.51 Million
CN¥8.77 Billion
≈ $1.28 Billion
+4.93pp
2016-12-31 2.83% CN¥197.50 Million
≈ $28.90 Million
CN¥6.98 Billion
≈ $1.02 Billion
+1.79pp
2015-12-31 1.03% CN¥47.00 Million
≈ $6.88 Million
CN¥4.55 Billion
≈ $665.33 Million
--
pp = percentage points

About Yifan Xinfu Pharmaceutical Co Ltd

SHE:002019 China Drug Manufacturers - General
Market Cap
$1.70 Billion
CN¥11.59 Billion CNY
Market Cap Rank
#6539 Global
#1271 in China
Share Price
CN¥9.53
Change (1 day)
+1.28%
52-Week Range
CN¥9.10 - CN¥14.45
All Time High
CN¥32.51
About

Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products, vitamins, and polymer materials in China, South Korea, the Philippines, Vietnam, Italy, Thailand, and internationally. It offers pharmaceutical products, such as biopharmaceuticals, chemical drugs, and traditional Chinese medicines; vitamin products, including vitamin B5 and provi… Read more